Epilepsy & Behavior · 2016 · 12 citations · 13 references
PharmacyPediatricsPharmacotherapyPediatric Clinical PharmacologyPediatric PharmacotherapyPediatric TherapeuticsPediatric Clinical TrialsPediatric PharmacokineticsPediatric PharmacologyAccess To Pediatric MedicationsFda Drug RegulationPediatric Adverse Drug Event ReportingPediatric Clinical PharmacotherapyPediatric Drug ApprovalVigabatrin Therapy
13
Severe persistent visual field constriction associated with vigabatrin: FIG 1
Tom Eke, J F Talbot, Mark Lawden · BMJ · 1997 · 451 citations
Medicine, Neurology, Neuroscience +17
Evidence-based guideline update: Medical treatment of infantile spasms [RETIRED]
Cristina Go, Mark T. Mackay, Shelly K. Weiss et al. · Neurology · 2012 · 337 citations · Full text
Medicine, Neurology, Pharmacotherapy +13
Vigabatrin-associated retinal cone system dysfunction
Gregory L. Krauss, Mary A. Johnson, Neil R. Miller · Neurology · 1998 · 249 citations
Randomized trial of vigabatrin in patients with infantile spasms
Roy D. Elterman, W. Donald Shields, K. A. Mansfield et al. · Neurology · 2001 · 222 citations
Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
Reetta Kälviäinen, Iiris Nousiainen, Maija Mäntyjärvi et al. · Neurology · 1999 · 200 citations
Medicine, Neurology, Ophthalmology +16